These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 87265)

  • 21. Tumorigenicity of simian virus 40-transformed rat hepatocytes.
    Isom HC; Tevethia MJ; Kreider JW
    Cancer Res; 1981 Jun; 41(6):2126-34. PubMed ID: 6263461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancer.
    Ross DS; Steele G; Madara J; Lahey SJ; Ravikumar TS; Wilson RE; Munroe AE; Wright D; King VP
    J Natl Cancer Inst; 1984 Sep; 73(3):731-5. PubMed ID: 6590917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to an allogeneic progressively growing solid tumor.
    Eggers AE
    Cancer Res; 1976 Jun; 36(6):2085-9. PubMed ID: 773534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas.
    Ménoret A; Patry Y; Burg C; Le Pendu J
    J Immunol; 1995 Jul; 155(2):740-7. PubMed ID: 7608552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.
    Sato N; Kikuchi K
    J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumorigenicity of continuous monkey cell lines in in vivo and in vitro systems.
    Johnson JB; Noguchi PD; Browne WC; Petricciani JC
    Dev Biol Stand; 1981; 50():27-35. PubMed ID: 6804291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
    Schiller JH; Bittner G
    Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune reactions against hepatitis B viral antigens lead to the rejection of hepatocellular carcinoma in BALB/c mice.
    Chen SH; Hu CP; Lee CK; Chang C
    Cancer Res; 1993 Oct; 53(19):4648-51. PubMed ID: 8402642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
    Flood PM; Schreiber H; Ron Y
    J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
    Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of transplantable tumors by adoptive transfer of spleen cells from immunized rats.
    Fish DC; Djurickovic DB; Huebner RJ
    J Immunol; 1979 Dec; 123(6):2658-63. PubMed ID: 501086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization by irradiated whole cells or cell extracts against an experimental bladder tumor.
    Morales A; Djeu J; Herberman RB
    Invest Urol; 1980 Jan; 17(4):310-3. PubMed ID: 7351363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
    Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
    Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions.
    Shu S; Steerenberg PA; Hunter JT; Evans CH; Rapp HJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3499-506. PubMed ID: 7260913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.
    Levitt ML; Gazdar AF; Oie HK; Schuller H; Thacher SM
    Cancer Res; 1990 Jan; 50(1):120-8. PubMed ID: 1967140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine.
    Anderson LD; Petropoulos D; Everse LA; Mullen CA
    Cancer Res; 1999 Apr; 59(7):1525-30. PubMed ID: 10197624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.